➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Moodys
Harvard Business School

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DYDROGESTERONE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Dydrogesterone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00145522 ↗ Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women Completed Solvay Pharmaceuticals Phase 4 2005-11-01 This study is to evaluate the effects of continuously combined 17b-estradiol/dydrogesterone in comparison with tibolone on the breast metabolic markers, in particular the total insulin-like growth factor-1 (IGF-1), in postmenopausal women.
NCT00160316 ↗ Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination Completed Solvay Pharmaceuticals Phase 3 2005-04-01 The purpose of this study is to demonstrate endometrial safety of continuous combined 0.5 mg estradiol and 2.5 mg dydrogesterone.
NCT00193674 ↗ Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage Completed Abbott Products Phase 3 2003-09-01 The purpose of this clinical study is to demonstrate the shift from inflammatory cytokines to non-inflammatory cytokines in women suffering from habitual abortion treated with dydrogesterone (Duphaston).
NCT00251082 ↗ Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination Completed Solvay Pharmaceuticals Phase 3 2005-12-01 To demonstrate efficacy of continuous combined 0.5 mg estradiol and 2.5 mg dydrogesterone versus placebo in the treatment of vasomotor symptoms after a treatment period of 3 months and to investigate the bleeding pattern over a treatment period of one year
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dydrogesterone

Condition Name

Condition Name for Dydrogesterone
Intervention Trials
Infertility 7
Infertility, Female 5
Preterm Labor 3
Dydrogesterone 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dydrogesterone
Intervention Trials
Infertility 14
Infertility, Female 7
Abortion, Spontaneous 5
Premature Birth 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dydrogesterone

Trials by Country

Trials by Country for Dydrogesterone
Location Trials
Thailand 6
China 6
Egypt 4
Croatia 3
Russian Federation 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dydrogesterone

Clinical Trial Phase

Clinical Trial Phase for Dydrogesterone
Clinical Trial Phase Trials
Phase 4 14
Phase 3 11
Phase 2/Phase 3 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dydrogesterone
Clinical Trial Phase Trials
Not yet recruiting 15
Completed 13
Recruiting 9
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dydrogesterone

Sponsor Name

Sponsor Name for Dydrogesterone
Sponsor Trials
Chulalongkorn University 3
Solvay Pharmaceuticals 3
Abbott 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dydrogesterone
Sponsor Trials
Other 54
Industry 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Johnson and Johnson
McKinsey
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.